tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chris Howerton, 142 are a BUY (82.08%), 29 are a HOLD (16.76%), 2 are a SELL (1.16%).
Analyst Chris Howerton, carries an average stock price target met ratio of 51.68% that have a potential upside of 40.56% achieved within 243 days. Previously, Chris Howerton worked at JEFFERIES.
Chris Howerton’s has documented 332 price targets and ratings displayed on 54 stocks. The coverage was on Healthcare, Consumer Cyclical, Technology sectors.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 26-Feb-2026.
Analyst best performing recommendations are on PSTI (PLURISTEM).
The best stock recommendation documented was for NERV (MINERVA NEUROSCIENCES) at 5/12/2016. The price target of $80 was fulfilled within 14 days with a profit of $35.44 (79.53%) receiving and performance score of 56.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jun-2025
$36
$16.22 (82.00%)
$37
Buy Since 15-Dec-2025
$33
$13.22 (66.84%)
$37
18 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$14.22 (71.89%)
$36
18 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 25-Sep-2025
$31
$11.22 (56.72%)
$38
18 days ago
(25-Sep-2026)
1/4 (25%)
$10.32 (49.90%)
831
Buy Since 28-Feb-2024
$35
$15.22 (76.95%)
$41
18 days ago
(25-Sep-2026)
9/15 (60%)
$14.32 (69.25%)
393
